Laddar...
Suvorexant: a promising, novel treatment for insomnia
Suvorexant a novel, orexin receptor antagonist was recently approved by the US Food and Drug Administration for the treatment of sleep onset and sleep maintenance insomnia in August 2014. Multiple animal and human studies support the efficacy, safety, and tolerability of suvorexant for patients of v...
Sparad:
| I publikationen: | Neuropsychiatr Dis Treat |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772996/ https://ncbi.nlm.nih.gov/pubmed/26955275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S31495 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|